Thus, Ctip inactivation inhibits the formation of mammary tumors caused by either homozygous or heterozygous p53 gene inactivation (Figure 4) or by a dominant-negative p53 missense mutation frequently observed in human breast cancer (Figure 6). This evidence concerns the gene TP53 and breast carcinoma.